Table 6.
The extent of inactivation (log10 reduction) of parasites in platelet components by the INTERCEPT Blood System (official label claims)
| Parasites | Extent of inactivation* (log10 reduction) |
|---|---|
| Plasmodium falciparum**(malaria) | ≥6.0 |
| Trypanosoma cruzi (Chagas' disease) | >5.3 |
| Leishmania mexicana (metacyclic promastigote stage) | >5.0 |
| Leishmania major Jish (amastigote stage) | >4.3 |
| Babesia microti (babesiosis) | >5.3 |
*
‘>’ refers to inactivation below the limit of detection of the assay.
**
Intracellular.